These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12062497)

  • 21. [Preparation and in vitro study of buagafuran solid dispersions].
    Xia XJ; Tao ZH; Ren Y; Wang RY; Liu YL
    Yao Xue Xue Bao; 2008 May; 43(5):548-52. PubMed ID: 18717346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex amorphous solid dispersions based on poly(2-hydroxyethyl methacrylate): Study of drug release from a hydrophilic insoluble polymeric carrier in the presence and absence of a porosity increasing agent.
    Everaerts M; Van den Mooter G
    Int J Pharm; 2019 Jul; 566():77-88. PubMed ID: 31103819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.
    Liu C; Liu C; Desai KG
    Drug Dev Ind Pharm; 2005 Jan; 31(1):1-10. PubMed ID: 15704852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method.
    Sethia S; Squillante E
    J Pharm Sci; 2002 Sep; 91(9):1948-57. PubMed ID: 12210042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
    Urbanetz NA
    Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
    Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
    J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterisations of the physical, solid dispersed and eutectic mixtures.
    Naima Z; Siro T; Juan-Manuel GD; Chantal C; René C; Jerome D
    Eur J Pharm Sci; 2001 Feb; 12(4):395-404. PubMed ID: 11231106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New metastable form of glibenclamide prepared by redispersion from ternary solid dispersions containing polyvinylpyrrolidone-K30 and sodium lauryl sulfate.
    Thongnopkoon T; Puttipipatkhachorn S
    Drug Dev Ind Pharm; 2016 Jan; 42(1):70-79. PubMed ID: 25835067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of domperidone solid dispersions.
    Essa EA; Balata GF
    Pak J Pharm Sci; 2012 Oct; 25(4):783-91. PubMed ID: 23009995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution enhancement of carbamazepine using twin-screw melt granulation.
    Steffens KE; Wagner KG
    Eur J Pharm Biopharm; 2020 Mar; 148():77-87. PubMed ID: 31954840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of Indomethacin in Semicrystalline Dispersions: Formation, Transformation, and Segregation.
    Van Duong T; Lüdeker D; Van Bockstal PJ; De Beer T; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2018 Mar; 15(3):1037-1051. PubMed ID: 29307188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.
    Janssens S; de Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1114-20. PubMed ID: 18502629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions.
    Zerrouk N; Chemtob C; Arnaud P; Toscani S; Dugue J
    Int J Pharm; 2001 Aug; 225(1-2):49-62. PubMed ID: 11489554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical characterization of artemether solid dispersions with hydrophilic carriers by freeze dried and melt methods.
    Ansari MT; Karim S; Ranjha NM; Shah NH; Muhammad S
    Arch Pharm Res; 2010 Jun; 33(6):901-10. PubMed ID: 20607495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.
    Suhagia BN; Patel HM; Shah SA; Rathod I; Parmar VK
    Acta Pharm; 2006 Sep; 56(3):285-98. PubMed ID: 19831278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets.
    Ullah M; Ullah H; Murtaza G; Mahmood Q; Hussain I
    Biomed Res Int; 2015; 2015():870656. PubMed ID: 26380301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
    Dhumal RS; Biradar SV; Aher S; Paradkar AR
    J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.